Tier 3 · Filer Universe
aTYR PHARMA INC
ATYR · Nasdaq · Healthcare. Identity, market observation, SEC facts, and source links remain separate and inspectable.
Price
$0.51
+0.00%
Coverage
Tier 3
Tier 3 · Filer Universe
SEC CIK
0001339970
Liquidity rank
#4613
Observed dollar volume
Tier 3 is a directory treatment. It does not imply options, analyst estimates, or complete company-facts coverage. Missing fields stay missing.
SEC XBRL facts
| Field | Value | Period end | Filing |
|---|---|---|---|
| Annual revenue | $190,000.00 | 2025-12-31 | 0001339970-26-000008 |
| Annual diluted EPS | -0.8 | 2025-12-31 | 0001339970-26-000008 |
| Quarterly revenue | $190,000.00 | 2025-09-30 | 0001193125-25-269587 |
| Quarterly diluted EPS | -0.11 | 2026-03-31 | 0001339970-26-000033 |
SEC EDGAR Frames batch generated 2026-07-16T23:27:27.036Z. Frames are calendar-aligned and may not cover every filer or fiscal period.
Filings and machine access
Latest SEC filingsSEC company browse
SEC submissions JSONDirect upstream record
Per-symbol JSONSame-origin machine contract
Context paths
HealthcareNasdaqBMY · Tier 1 peerTMO · Tier 1 peerDHR · Tier 1 peerAMGN · Tier 1 peer
Provenance
Quote and corporate actionsYahoo Finance chart
FundamentalsSEC EDGAR Frames